BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06926868-completion@plaintrial.com
DTSTAMP:20261028T050505Z
DTSTART;VALUE=DATE:20300515
SUMMARY:A Study of Izalontamab Brengitecan Versus Chemotherapy in Participa
 nts With Previously Untreated\, Locally Advanced\, Recurrent Inoperable\, 
 or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Dru
 gs (IZABRIGHT-Breast01) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06926868
URL:https://plaintrial.com/trial/NCT06926868
END:VEVENT
END:VCALENDAR